
Alphatec Hlds (ATEC) Stock Forecast & Price Target
Alphatec Hlds (ATEC) Analyst Ratings
Bulls say
Alphatec Holdings Inc. has demonstrated a robust financial performance, highlighted by a 28% growth in surgical revenue to $157 million in the fourth quarter of 2024, alongside a substantial 19% increase in procedure volumes. The company's adjusted operating margin significantly improved to 2.6%, marking a 1,000 basis point increase year-over-year, which notably outperformed consensus expectations. Furthermore, for 2025, Alphatec anticipates total revenues of $732 million, reflecting an approximate 20% increase over preliminary 2024 revenues, indicating solid prospects for durable growth and profitability.
Bears say
Alphatec Holdings Inc. reported an adjusted gross margin of 69.7%, which remained flat year-over-year and fell short of the consensus estimate of 70.0%, indicating potential challenges in cost management and pricing power. The company's EBITDA guidance of $75 million reflects a concerning 37% drop-through rate on incremental revenue growth, raising alarms about its efficiency in converting revenue into earnings amid anticipated pressure on free cash flow. Furthermore, risks such as poor sales execution, increased competition in the spinal market, and ongoing procedure volume disruptions stemming from the COVID-19 pandemic contribute to a pessimistic outlook for the company's future financial performance.
This aggregate rating is based on analysts' research of Alphatec Hlds and is not a guaranteed prediction by Public.com or investment advice.
Alphatec Hlds (ATEC) Analyst Forecast & Price Prediction
Start investing in Alphatec Hlds (ATEC)
Order type
Buy in
Order amount
Est. shares
0 shares